Protocol Ledger

NCT03550391 · Phase III · RECRUITING

Stereotactic Radiosurgery Compared With Hippocampal-Avoidant Whole Brain Radiotherapy (HA-WBRT) Plus Memantine for 5 or More Brain Metastases

Interventional Phase III clinical trial protocol NCT03550391 sponsored by Canadian Cancer Trials Group in Rare Genetic, Women's Health, and Other, reconciled from NIH NLM ClinicalTrials.gov REST API v2.

Start Date: 2018-11-22 Enrollment: 206 participants (ESTIMATED) Federal Source: clinicaltrials.gov/study/NCT03550391
Track in Studio / Generate Client Brief ->
Registered Enrollment vs Phase II/III Median (145 pts)206 participants (ESTIMATED)
Disclosed U.S. Hospital Campuses vs Median (6 sites)4 sites

Reconciled ClinicalTrials.gov v2 Protocol Specification

Structured Registry Fields for NCT03550391
Protocol FieldVerified Registry Value
NCT IdentifierNCT03550391
Consolidated Lead SponsorCanadian Cancer Trials Group
Therapeutic Condition CohortRare Genetic, Women's Health, and Other
Clinical Trial PhasePhase III
Overall Recruitment StatusRECRUITING
Registered Enrollment206 participants (ESTIMATED)
Registered Start Date2018-11-22
WhyStopped ClassificationNot Stopped

Named U.S. Hospital Clinical Research Sites

Search related sites and sponsors in the Interactive Directory, explore Rare Genetic, Women's Health, and Other Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.

Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI